Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope

We previously developed a panel of neutralizing monoclonal antibodies against Dengue virus (DENV)-1, of which few exhibited inhibitory activity against all DENV-1 genotypes. This finding is consistent with reports observing variable neutralization of different DENV strains and genotypes using serum from individuals that experienced natural infection or immunization. Herein, we describe the crystal structures of DENV1-E111 bound to a novel CC′ loop epitope on domain III (DIII) of the E protein from two different DENV-1 genotypes. Docking of our structure onto the available cryo-electron microscopy models of DENV virions revealed that the DENV1-E111 epitope was inaccessible, suggesting that this antibody recognizes an uncharacterized virus conformation. While the affinity of binding between DENV1-E111 and DIII varied by genotype, we observed limited correlation with inhibitory activity. Instead, our results support the conclusion that potent neutralization depends on genotype-dependent exposure of the CC′ loop epitope. These findings establish new structural complexity of the DENV virion, which may be relevant for the choice of DENV strain for induction or analysis of neutralizing antibodies in the context of vaccine development.

[1]  V. Barban,et al.  Broad neutralization of wild-type dengue virus isolates following immunization in monkeys with a tetravalent dengue vaccine based on chimeric yellow fever 17D/dengue viruses. , 2012, Virology.

[2]  D. Burton,et al.  Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses , 2012, Science.

[3]  C. Midgley,et al.  Structural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-Reactivity , 2012, The Journal of Immunology.

[4]  Hugues Bedouelle,et al.  Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody. , 2012, Structure.

[5]  Elena Zaitseva,et al.  Structural insights into the neutralization mechanism of a higher primate antibody against dengue virus , 2012, The EMBO journal.

[6]  Gregory D. Gromowski,et al.  Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypes. , 2012, Virology.

[7]  D. Fremont,et al.  Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature. , 2012, Virology.

[8]  T. Pierson,et al.  A Dynamic Landscape for Antibody Binding Modulates Antibody-Mediated Neutralization of West Nile Virus , 2011, PLoS pathogens.

[9]  Cameron P Simmons,et al.  The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. , 2010, Cell host & microbe.

[10]  Soila Sukupolvi-Petty,et al.  Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3 , 2010, Journal of Virology.

[11]  R. Rico-Hesse,et al.  Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2 , 2010, Journal of Virology.

[12]  C. Nelson,et al.  The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1 , 2010, PLoS pathogens.

[13]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[14]  Ralph S. Baric,et al.  Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses , 2010, PLoS pathogens.

[15]  Tyler R. Prestwood,et al.  Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. , 2010, Cell host & microbe.

[16]  M. Diamond,et al.  Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification , 2010, PLoS pathogens.

[17]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[18]  D. Fremont,et al.  Capturing a Flavivirus Pre-Fusion Intermediate , 2009, PLoS pathogens.

[19]  G. Nybakken,et al.  Structural basis for the preferential recognition of immature flaviviruses by a fusion‐loop antibody , 2009, The EMBO journal.

[20]  M. Guzmán,et al.  Antibodies Induced by Dengue Virus Type 1 and 2 Envelope Domain III Recombinant Proteins in Monkeys Neutralize Strains with Different Genotypes , 2009, Clinical and Vaccine Immunology.

[21]  K. Stiasny,et al.  Impact of Quaternary Organization on the Antigenic Structure of the Tick-Borne Encephalitis Virus Envelope Glycoprotein E , 2009, Journal of Virology.

[22]  D. Fremont,et al.  A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes , 2009, PLoS pathogens.

[23]  T. Pierson,et al.  Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step , 2009, Journal of Virology.

[24]  Crystal Structure of Dengue Virus Type 1 Envelope Protein in the Postfusion Conformation and Its Implications for Membrane Fusion , 2009, Journal of Virology.

[25]  Mauricio Carrillo-Tripp,et al.  VIPERdb2: an enhanced and web API enabled relational database for structural virology , 2008, Nucleic Acids Res..

[26]  T. Pierson,et al.  Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation. , 2008, Virology.

[27]  M. Guzmán,et al.  Neutralizing antibody response variation against dengue 3 strains , 2008, Journal of medical virology.

[28]  D. Fremont,et al.  Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. , 2008, Cell host & microbe.

[29]  Paolo Marcatili,et al.  PIGS: automatic prediction of antibody structures , 2008, Bioinform..

[30]  T. Pierson,et al.  Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization , 2008, PLoS pathogens.

[31]  Wei Zhang,et al.  Structure of the Immature Dengue Virus at Low pH Primes Proteolytic Maturation , 2008, Science.

[32]  Ying Zhang,et al.  The Flavivirus Precursor Membrane-Envelope Protein Complex: Structure and Maturation , 2008, Science.

[33]  Richard J Kuhn,et al.  Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins , 2008, Nature Structural &Molecular Biology.

[34]  M. Guzmán,et al.  Primary and Secondary Infections of Macaca fascicularis Monkeys with Asian and American Genotypes of Dengue Virus 2 , 2007, Clinical and Vaccine Immunology.

[35]  J. Abd-Jamil,et al.  Antibody neutralization and viral virulence in recurring dengue virus type 2 outbreaks. , 2007, Viral immunology.

[36]  Gregory D. Gromowski,et al.  Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. , 2007, Virology.

[37]  R. Purcell,et al.  Epitope Determinants of a Chimpanzee Dengue Virus Type 4 (DENV-4)-Neutralizing Antibody and Protection against DENV-4 Challenge in Mice and Rhesus Monkeys by Passively Transferred Humanized Antibody , 2007, Journal of Virology.

[38]  Gregory D. Gromowski,et al.  Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes , 2007, Journal of Virology.

[39]  G. Nybakken,et al.  Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus , 2007, Journal of Virology.

[40]  M. St. Claire,et al.  Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention , 2007, Proceedings of the National Academy of Sciences.

[41]  G. Nybakken,et al.  The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. , 2007, Cell host & microbe.

[42]  T. Oliphant,et al.  Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein , 2006, Journal of Virology.

[43]  K. Stiasny,et al.  Cryptic Properties of a Cluster of Dominant Flavivirus Cross-Reactive Antigenic Sites , 2006, Journal of Virology.

[44]  G. Nybakken,et al.  West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody , 2006, Proceedings of the National Academy of Sciences.

[45]  A. Zemla,et al.  Antibody elbow angles are influenced by their light chain class. , 2006, Journal of molecular biology.

[46]  T. Oliphant,et al.  Structural basis of West Nile virus neutralization by a therapeutic antibody , 2005, Nature.

[47]  F. Studier,et al.  Protein production by auto-induction in high density shaking cultures. , 2005, Protein expression and purification.

[48]  Fei Long,et al.  REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use. , 2004, Acta crystallographica. Section D, Biological crystallography.

[49]  K. Stiasny,et al.  Structure of a flavivirus envelope glycoprotein in its low‐pH‐induced membrane fusion conformation , 2004, The EMBO journal.

[50]  Y. Modis,et al.  Structure of the dengue virus envelope protein after membrane fusion , 2004, Nature.

[51]  Bong-Suk Kim,et al.  Structure of West Nile Virus , 2003, Science.

[52]  Y. Modis,et al.  A ligand-binding pocket in the dengue virus envelope glycoprotein , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Edward C Holmes,et al.  The origin, emergence and evolutionary genetics of dengue virus. , 2003, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[54]  S. Halstead,et al.  Neutralization and antibody-dependent enhancement of dengue viruses. , 2003, Advances in virus research.

[55]  S. Halstead,et al.  Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever , 2002, The Lancet.

[56]  Wei Zhang,et al.  Structure of Dengue Virus Implications for Flavivirus Organization, Maturation, and Fusion , 2002, Cell.

[57]  J. Roehrig,et al.  Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells , 2001, Journal of Virology.

[58]  J. Roehrig,et al.  Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. , 1998, Virology.

[59]  A. Plückthun,et al.  Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. , 1997, Journal of immunological methods.

[60]  Robert M. Sweet,et al.  Macromolecular Crystallography: Part A , 1997 .

[61]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[62]  J. Sadoff,et al.  Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys. , 1996, The Journal of infectious diseases.

[63]  R. Rico-Hesse,et al.  Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. , 1990, Virology.

[64]  S. Halstead,et al.  Hemorrhagic fever in Thailand; recent knowledge regarding etiology. , 1967, Japanese journal of medical science & biology.

[65]  A. Sabin Research on dengue during World War II. , 1952, The American journal of tropical medicine and hygiene.